Replies to post #538492 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Horse,
Thanks for your reply.

I have no doubt that both BMY and Merck fully understand the value of NWBO. BMY's close collaborator (Universidad de Navarra) did extensive research on the combo trials using dendritic cell which were completed or nearly completed before BMY struck the trial deal with NWBO.

Here are the trials on dendritic cell by Universidad de Navarra. I haven't read any publication of special significance from these trials, which is not surprising. Otherwise BMY would not come NWBO for collaboration. NWBO has something that BPs hunger for.

Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection
https://clinicaltrials.gov/ct2/show/NCT01006044?cond=dendritic&draw=2&rank=44

Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer
https://clinicaltrials.gov/ct2/show/NCT01431196?cond=dendritic&draw=2&rank=73

Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS) (TOLERVIT-MS)
https://clinicaltrials.gov/ct2/show/NCT02903537?cond=dendritic&draw=2&rank=77

Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults (DEND/TIA)
https://clinicaltrials.gov/ct2/show/NCT02496520?cond=dendritic&draw=2&rank=84

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma
https://clinicaltrials.gov/ct2/show/NCT01348256?cond=dendritic&draw=2&rank=86

Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT01734564?cond=dendritic&draw=3&rank=192

Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT00610389?cond=dendritic&draw=4&rank=279